Dr. Mark A. Dosmann, M.D.
Radiation Oncology (Radiation Oncology Physician)
At a glance
- In the NPI registry since
- 2007
Licensed in Texas since 1994, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Radiation Oncology Physician primary
TX license J5088 (first issued 1994; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Payments from drug and device companies
In 2025, 6 companies reported 7 payments worth $166 in total to this clinician.
| Sobi, Inc | $39.68 |
|---|---|
| Merck Sharp & Dohme LLC | $31.20 |
| Daiichi Sankyo Inc. | $27.35 |
| Regeneron Healthcare Solutions, Inc. | $24.64 |
| Incyte Corporation | $24.06 |
| AstraZeneca Pharmaceuticals LP | $19.27 |
| Food and Beverage | $166 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.